Sign in
Delayed neutrophil engraftment in patients receiving Daratumumab as part of their first induction regimen for multiple myeloma
Journal article   Peer reviewed

Delayed neutrophil engraftment in patients receiving Daratumumab as part of their first induction regimen for multiple myeloma

Abdullah S Al Saleh, M Hasib Sidiqi, Morie A Gertz, Eli Muchtar, Martha Q Lacy, Rahma M Warsame, Wilson I Gonsalves, Taxiarchis V Kourelis, William J Hogan, Suzanne R Hayman, …
American journal of hematology, Vol.95(1), pp.E8-E10
01/2020
PMID: 31591735

Abstract

Aged Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use Delayed Graft Function Female Graft Survival - drug effects Hematopoietic Stem Cell Transplantation - methods Humans Induction Chemotherapy - adverse effects Induction Chemotherapy - methods Male Middle Aged Multiple Myeloma - therapy Neutrophils - physiology Retrospective Studies Transplantation, Autologous

Metrics

1 Record Views

Details